June 14, 2021
Amid significant controversy, the US Food and Drug Administration (FDA) last week approved the antiamyloid agent aducanumab (Aduhelm) for the treatment of Alzheimer’s disease, disregarding the […]
June 11, 2021
The piercing sound was so loud that night it awoke the official assigned to the US embassy in Cuba who was trying to sleep at home […]
June 10, 2021
A phase 3, sham-controlled clinical trial of an external trigeminal nerve stimulation (e-TNS) device showed confirmed superiority over a sham device and eliminated the most bothersome […]
June 10, 2021
Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Another study has suggested that rates of cerebral venous sinus thrombosis (CVST) […]
June 9, 2021
Two members of the US Food and Drug Administration’s (FDA’s) Peripheral and Central Nervous System Drugs Advisory Committee have resigned following the agency’s approval of the […]
June 9, 2021
OnabotulinumtoxinA alone provides relief from chronic migraine, and addition of anti-calcitonin gene-related peptide (CGRP) antibodies may boost the benefit, according to a large retrospective analysis. The […]
June 9, 2021
Patients overwhelmingly found telemedicine care for headache a satisfactory and beneficial experience during the COVID-19 pandemic, according to a study presented at the American Headache Society’s 2021 […]
June 9, 2021
Apparent migraines experienced by 19th century factory workers remain relevant to clinical medicine today. Those workers were employed in the manufacture of nitroglycerine, and many became […]
June 8, 2021
The US Food and Drug Administration (FDA) has approved Medtronic’s technologically advanced deep brain stimulation (DBS) system designed to more precisely target motor symptoms in Parkinson’s […]